Grifols Therapeutics Inc.

Active Research Triangle Park, NC

Grifols Therapeutics Inc. Overview

Grifols Therapeutics Inc. filed as a Foreign Business Corporation in the State of New York on Friday, March 4, 2005 and is approximately twenty years old, according to public records filed with New York Department of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. This does not necessarily mean that they are from outside the United States.

Name
Sergi Roura 1 ~ Background Report ~	Chief Executive Officer President CEO
Gregory G. Rich 7 ~ Background Report ~	President
Lawrence Stern 1 ~ Background Report ~	President

California Secretary of State

Filing Type:	Statement & Designation By Foreign Corporation
Status:	Inactive
State:	California
Foreign State:	Delaware
State ID:	02725145
Date Filed:	Thursday, March 3, 2005

New York Department of State

Filing Type:	Foreign Business Corporation
Status:	Active
State:	New York
Foreign State:	Delaware
County:	NEW YORK
State ID:	3172873
Date Filed:	Friday, March 4, 2005
DOS Process	C/O C T Corporation System
Source Record	NY DOS

Corporate Notes

Source	Date	Type	Note
	3/4/2005	Name History/Actual	Talecris Biotherapeutics, Inc.
	8/24/2011	Name History/Actual	Grifols Therapeutics Inc.

Trademarks for Grifols Therapeutics Inc.

	Talecris Serial Number: 78551985 Drawing Code: 4000
	Serial Number: 78151742 Drawing Code: 2000
	Talecris Direct Serial Number: 78703084 Drawing Code: 4000
	Serial Number: 78151737 Drawing Code: 2000
	Talecris Biotherapeutics Serial Number: 78551989 Drawing Code: 4000
	Talecris Biotherapeutics Serial Number: 78552030 Drawing Code: 5000
	Gamunex Serial Number: 78031372 Drawing Code: 1000
	Gamunex Connexions Serial Number: 85525644 Drawing Code: 4000
	Thrombate III Serial Number: 74232095 Drawing Code:
	Hyperrho Serial Number: 78622902 Drawing Code: 4000